Posted On: 09/13/2013 8:00:14 AM
Post# of 63821

From Pharma Prs
NVAX
NVAX

- Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013
5:00 pm - PR Newswire

